OATES, Gabriela R., Irena ŠTĚPANÍKOVÁ, Steven M. ROWE, Stephanie GAMBLE, Hector H. GUTIERREZ and William T. HARRIS. Objective Versus Self-Reported Adherence to Airway Clearance Therapy in Cystic Fibrosis. RESPIRATORY CARE. IRVING: DAEDALUS ENTERPRISES INC, 2019, vol. 64, No 2, p. 176-181. ISSN 0020-1324. Available from: https://dx.doi.org/10.4187/respcare.06436.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Objective Versus Self-Reported Adherence to Airway Clearance Therapy in Cystic Fibrosis
Authors OATES, Gabriela R. (840 United States of America), Irena ŠTĚPANÍKOVÁ (203 Czech Republic, guarantor, belonging to the institution), Steven M. ROWE (840 United States of America), Stephanie GAMBLE (840 United States of America), Hector H. GUTIERREZ (840 United States of America) and William T. HARRIS (840 United States of America).
Edition RESPIRATORY CARE, IRVING, DAEDALUS ENTERPRISES INC, 2019, 0020-1324.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30203 Respiratory systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.066
RIV identification code RIV/00216224:14310/19:00110325
Organization unit Faculty of Science
Doi http://dx.doi.org/10.4187/respcare.06436
UT WoS 000457372700009
Keywords in English adherence; airway clearance; chest physical therapy; high-frequency chest wall compressions; cystic fibrosis
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 23/3/2020 17:00.
Abstract
BACKGROUND: Historically, studies of adherence to airway clearance therapy in cystic fibrosis (CF) have relied on self-reporting. We compared self-reported airway clearance therapy adherence to actual usage data from home high-frequency chest wall compressions (HFCWC) vests and identified factors associated with overestimation of adherence in self-reports. METHODS: Pediatric patients who perform airway clearance therapy with a HFCWC vest were eligible to participate. Objective adherence data were obtained from the HFCWC device, which records cumulative utilization time. Two readings at least 5 weeks apart were collected. Objective adherence was recorded as a ratio of mean-to-prescribed daily use (%). Self-reported adherence data were collected with a caregiver survey at enrollment. Adherence rates were categorized as low (< 35% of prescribed), moderate (36-79% of prescribed), and high (>= 80% of prescribed). An overestimation was present when self-reported adherence was at least one category higher than objective adherence. RESULTS: In the final sample (N = 110), mean adherence by usage data was 61%. Only 35% of subjects (n = 38) were highly adherent, and 28% (n = 31) were low adherent. In contrast, 65% of subjects (n = 72) reported high adherence and only 8% (n = 9) reported low adherence (P < .001). Nearly half of self-reports (46%) overestimated adherence. In a multiple regression analysis, overestimation was associated with multiple airway clearance therapy locations (odds ratio 7.13, 95% CI 1.16-43.72, P = .034) and prescribed daily use >= 60 min (odds ratio 3.85, 95% CI 1.08-13.76, P < .038). Among subjects with prescribed daily airway clearance therapy >= 60 min, the odds of overestimating adherence increased 3-fold (odds ratio 3.04, 95% CI 1.17-7.87, P = .02) in a lower-income (< $50,000/y) environment. CONCLUSIONS: Self-reports overestimated actual adherence to airway clearance therapy, and the overestimation increased with treatment occurring in multiple households and prescribed therapy duration. Among participants with prescribed airway clearance therapy >= 60 min, overestimation increased with lower income. Objective measures of adherence are needed, particularly for lower-income children and those receiving treatments in multiple locations.
PrintDisplayed: 22/7/2024 09:24